The objective of the study was to compare the proportions of the recovery of pathogens of acute maxillary sinusitis in adults in the 4-year period prior to the 5-year period that followed the introduction of vaccination of children with the 7-valent pneumococcal vaccine (PCV7). Cultures were obtained through endoscopy from 385 adults with acute maxillary sinusitis, 156 between 1997 and 2000, and 229 between 2001 and 2005. One hundred and seventeen potentially pathogenic organisms were isolated from the cultures obtained between 1997 and 2000. The predominant organisms were Streptococcus pneumoniae (54 or 46 % of all isolates), Haemophilus influenzae non-type b (42 or 36 %), Moraxella catarrhalis (7 or 6 %), Streptococcus pyogenes (8 or 7 %) and Staphylococcus aureus (6 or 5 %). One hundred and sixty-seven potentially pathogenic organisms were isolated from the cultures obtained between 2001 and 2005. The most predominant organisms were H. influenzae non-type b (71 or 43 % of all isolates), Strep. pneumoniae (58 or 35 %), M. catarrhalis (13 or 8 %), Strep. pyogenes (12 or 7 %) and Staph. aureus (13 or 8 %). Significant statistical differences were noted in the rates of recovery of H. influenzae non-type b (P<0?05) and Strep. pneumoniae (P<0?05). A decrease occurred in the recovery of Strep. pneumoniae resistant to penicillin from 41 to 29 %, and an increase was noted in the isolation of beta-lactamase-producing H. influenzae from 33 to 39 %; however, neither change was statistically significant. These data illustrate that a significant shift occurred in the causative pathogens of acute maxillary sinusitis in adults in the 5 years after the introduction of vaccination of children with the PCV7 compared to the previous 4 years.
INTRODUCTION
The growing resistance to antimicrobial agents of all respiratory tract bacterial pathogens has made the management of bacterial sinusitis more difficult. Failure of antimicrobials to clear the infection can be due to persistence of the pathogen(s) because of inadequate pharmacokinetic and pharmacodynamic qualities of the antimicrobials, and the development of resistance to the antimicrobial used (Brook & Gober, 2004; Brook, 2005; Pichichero & Pichichero, 1995; Craig & Andes, 1996) . The Sinus and Allergy Partnership recently published guidelines for the diagnosis and optimal treatment of acute bacterial rhinosinusitis (Sinus and Allergy Health Partnership, 2004) . They based their recommendations on predicted bacterial efficacy rates from mathematical modelling of acute sinusitis based on pathogen distribution, resolution rates without treatment, and in vitro microbiological efficacy. Since the above recommendations are based on the frequency of recovery of the pathogenic organisms, awareness of the effect of the recent introduction of the Streptococcus pneumoniae conjugated vaccine (in April 2000) on the frequency of recovery of pathogens is of great practical use. A shift in the frequency of recovery of causative pathogens was recently demonstrated in children with acute otitis media (AOM) who were vaccinated with the 7-valent pneumococcal vaccine (PCV7) (Casey & Pichichero, 2004; Block et al., 2004) ; however, no evaluation of the effect on the introduction of the vaccine on the recovery of respiratory pathogens was done in adults.
This study compared the proportion of recovery of pathogens of acute maxillary sinusitis in the 4 years before and the 5 years after the introduction of vaccination of children with the PCV7.
METHODS
Patients. The population studied was middle class, residing in suburban locations in the vicinity of Washington, DC. The patients were consecutively seen in the outpatient clinic between 1997 and 2005 and were diagnosed as suffering from acute bacterial maxillary sinusitis. They each had symptoms lasting between 10 and 30 days. None had had ear or sinus infection for at least 3 months before their initial visit, and they had not received antimicrobial therapy for at least 2 months.
Patients' complaints included facial pain, frontal headache, purulent nasal discharge, fever and malaise. Occipitomental (Waters' view), lateral, oblique and verticomental views or computed tomography were obtained. Sinusitis was defined radiographically as complete sinus opacity, an air-fluid level, or mucous-membrane thickening of at least 6 mm in the maxillary sinus. For the Waters' view, mucosal thickening of the maxillary sinuses was measured as the shortest distance from the air-mucosal interface to the most lateral part of the maxillary sinus wall. Specimens were obtained through endoscopy and the sinus secretions were collected with calcium-alginate-tipped micro-swabs. The study was granted an Institutional Review Board approval.
Microbiology. Cultures were obtained using endoscopic aspiration before therapy using calcium alginate swabs that were immediately plated into media supportive of the growth of aerobic bacteria. The method of specimen collection has been described previously (Brook et al., 1996) . The collectors of cultures and the microbiologist were blinded to the patients' therapy. Specimens were processed semiquantitively, and organisms were identified using standard methods (Murray et al., 1995) . All isolates of Strep. pneumoniae were screened for penicillin susceptibility with a 1 mg oxacillin disc by the KirbyBauer disc-diffusion method. Intermediate resistance to penicillin was defined as a MIC of 0?1-1?0 mg ml 21 and high resistance to penicillin was defined as MIC ¢2?0 mg ml 21 .
MIC values of all antimicrobials were determined by the broth microdilution methodology following the guidelines of the National (Table 2 ). An increase was noted in the isolation of betalactamase-producing H. influenzae from 33 % between 1997 and 2000 to 39 % (Table 3) . However, neither of these changes was statistically significant.
DISCUSSION
These data illustrate that a statistically significant shift occurred in the causative pathogens of acute maxillary sinusitis in adults in the 5 years following the introduction pneumoniae to penicillin and a 6 % increase in the recovery of betalactamase-producing H. influenzae, these changes were not statistically significant.
The significant changes in the recovery of sinusitis pathogens in adults as a result of the introduction of the Strep. pneumoniae conjugated vaccine to children younger than 2 years may be due to indirect or herd immunity in adults. Our findings are in concordance with previous studies in Israel that observed an overall reduction in colonization by vaccine-type Strep. pneumoniae in the community due to herd immunity (Dagan, 2004) . The use of PCV7 was found to reduce nasopharyngeal acquisition of vaccine-specific serotypes of Strep. pneumoniae, which in turn reduced the incidence of pneumococcal disease among vaccinated as well as non-vaccinated individuals. Since most antibiotic resistance in Strep. pneumoniae is confined to vaccine-type serotypes, vaccine use also reduces antibiotic resistance (Givon-Lavi et al., 2003; O'Brien & Dagan, 2003) . Since we did not identify the serotypes of the Strep. pneumoniae isolates, we could not determine whether there was a change in the recovery of these serotypes after 2001.
A shift in the frequency of recovery of causative pathogens was recently demonstrated in children with AOM (Casey & Pichichero, 2004; Block et al., 2004) . Casey & Pichichero (2004) and resistant PNSP were 16 and 9 % versus 13 and 6 % pre-and post-PCV7, respectively. Post-PCV7, Gram-negative bacteria and beta-lactamaseproducing organisms accounted for two-thirds and onehalf of all AOM isolates, respectively. Further studies are needed to ascertain the continuous effects of PCV7 on the bacterial causes of acute sinusitis. It is important to carefully monitor the bacterial causes of sinusitis and whether replacement with potential virulent organisms and development of antibiotic resistance in nonvaccine-type pneumococci will occur over time.
